May 29, 2025
TOPLINE: Compared with digital mammography, digital breast tomosynthesis (also known as 3D mammography) improved specificity and reduced recall rates in women with a family history of […]
May 28, 2025
New data suggest that glucagon-like peptide 1 (GLP-1) receptor agonists, used to treat diabetes and obesity, may also help guard against obesity-related cancers. In a large […]
May 27, 2025
Supplemental imaging techniques could more than triple cancer detection in dense breasts compared with standard care alone, according to new research. The study, published in The […]
May 26, 2025
TOPLINE: Qualitative focus groups with patients with early-onset colorectal cancer (eoCRC) across seven European countries revealed significant diagnostic delays and limited access to age-appropriate support services. […]
May 26, 2025
The addition of lurbinectedin — a novel alkylating agent and transcription inhibitor — to first-line maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) improved survival […]
May 26, 2025
TOPLINE: Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity. Hydrogen sulfide (H2S) treatment restored chromatin interactions and enhanced immune […]
May 23, 2025
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion for Blenrep (belantamab mafodotin) for the […]
May 23, 2025
At its May 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) gave a conditional marketing authorization in the European […]
May 23, 2025
New findings from the phase 3 INAVO120 trial underscore the durable benefits of inavolisib added to standard therapy for PIK3CA-mutated hormone receptor–positive (HR+) human epidermal growth […]